Disease Spotlight: Multiple Sclerosis
Please check back later for more content.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
FDA Action Update, January 2026: Approvals, Acceptance, and Clearance
2
NeuroVoices: Katrina Bawden, MSN, MSCN, FNP-C, on Emerging Therapies and Women’s Health Priorities in Multiple Sclerosis
3
Tolebrutinib Cuts Brain Volume Loss Despite Missing Primary End Point in Phase 3 Primary Progressive MS Study
4
FDA Accepts New Drug Application for Orexin Agonist Oveporexton in Narcolepsy Type 1, Grants Priority Review
5